Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
We aim to compare carbetocin with misoprostol for the prevention of postpartum hemorrhage in
patients with severe preeclampsia. The primary outcome is postpartum haemorrhage (blood loss
of ≥ 500 ml) while our Secondary outcomes include use of additional uterotonics, need for
blood transfusion, maternal adverse drug reaction, maternal complications and maternal death